Phase I Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
Price : $35 *
At a glance
- Drugs Ciraparantag (Primary) ; Edoxaban
- Indications Haemorrhage
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Perosphere
- 17 Nov 2016 Results assessing safety, pharmacokinetic and pharmacodynamic effects published in the Thrombosis and Haemostasis.
- 25 Sep 2014 Protocol has been amended to change in the official title and treatment arm.
- 23 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.